What is Epidermolysis Bullosa?
It is caused by genetic mutation in protein that composes epidermis and the boundary of epidermis-derma. It is a rare hereditary disease that easily causes blisters in mild injury and pain in skin and mucous membrane.
- Currently developing treatment for epidermolysis bullosa using Tβ4.
- This pipeline was received orphan drug designation from the US FDA to develop the treatment of Epidermolysis Bullosa. Related link http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=165302
- Until now, there is no way of fully recovering for this disease and only symptomatic treatment for relief of symptoms is mainly being done. Developing this treatment is expected to give opportunities of the treatment to patients who are suffering from this disorder.(First-in-class)